Product Information
ATROPINE 1% EYE DROPS is a generic product labeled by Somerset Therapeutics, LLC, priced at $10.3450 per ML under NDC 70069071601. Its NADAC has been published 113 times since Aug 7, 2024.
FDA first approved this application on Apr 29, 2024. Its Orange Book therapeutic-equivalence code is AT2.
Strength
10 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069071601
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
ATROPINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA217791FDA Approved
4/29/2024
TE Code
AT2
On Market Since
5/24/2024
Pharmacological Classes
Price Statistics
The NADAC for ATROPINE 1% EYE DROPS has been published 113 times since Aug 7, 2024, and over the history we have for it it has declined 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3450 per ML |
|---|---|
| All-time high | $11.6141 (Jul 15, 2026) |
| All-time low | $10.3450 (Sep 23, 2026) |
| 52-week high | $11.6141 |
| 52-week low | $10.3450 |
| Median price | $11.4158 |
| Average price | $11.3234 |
| Largest weekly change | -10.9% (Sep 23, 2026) |
| Weeks tracked | 113 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Atropine Sulfate Monohydrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atropine Sulfate Monohydrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATROPINE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ATROPINE 1% EYE DROPS, manufactured by Somerset Therapeutics, LLC, is $10.3450 per ML (NDC 70069071601), effective Sep 30, 2026.
How has the price of ATROPINE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ATROPINE 1% EYE DROPS has declined 4.1%. It has been tracked across 113 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for ATROPINE 1% EYE DROPS?
Since Aug 7, 2024, the NADAC for ATROPINE 1% EYE DROPS has ranged from a low of $10.3450 (Sep 23, 2026) to a high of $11.6141 (Jul 15, 2026), with a median of $11.4158 per ML.
Are there cheaper alternatives to ATROPINE 1% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of ATROPINE 1% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ATROPINE 1% EYE DROPS?
ATROPINE 1% EYE DROPS (NDC 70069071601) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.